Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Antoine Courgeon has worked on the following 46 EPO patent applications which have been published in the last five years:

EP11711395

STREPTOCOCCUS THERMOPHILUS BACTERIUM

IPC classification:
A23C 9/123, A23C 19/032, C07K 14/315, C12N 15/74
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Inc.
Status:
APPLICATION WITHDRAWN
EP11768149

IMMUNOGENIC COMPOSITIONS

IPC classification:
A61K 39/385, A61P 31/04
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12723748

ANTIPYRETICS TO ENHANCE TOLERABILITY OF VESICLE-BASED VACCINES

IPC classification:
A61K 31/167, A61K 35/74, A61K 38/16, A61P 43/00
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Inc.
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12702153

RSV IMMUNIZATION REGIMEN

IPC classification:
A61K 39/155, A61P 31/14
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12743037

COMPOSITIONS AND METHODS FOR ASSESSING FUNCTIONAL IMMUNOGENICITY OF PARVOVIRUS VACCINES

IPC classification:
C07K 14/005, C12Q 1/68, G01N 33/53
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12718460

ADJUVANT NANOEMULSIONS WITH PHOSPHOLIPIDS

IPC classification:
A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12722057

PRE-FUSION RSV F ANTIGENS

IPC classification:
C07K 14/135
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12753488

ADJUVANTED FORMULATIONS OF STAPHYLOCOCCUS AUREUS ANTIGENS

IPC classification:
A61K 39/085, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12797981

ADJUVANTED INFLUENZA B VIRUS VACCINES FOR PEDIATRIC PRIMING

IPC classification:
A61K 39/145, A61P 31/16
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12778013

RECOMBINANT SELF-REPLICATING POLYCISTRONIC RNA MOLECULES

IPC classification:
A61K 39/245, A61K 39/25, C12N 15/86
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12788647

CARRIER MOLECULE COMPRISING A SPR0096 AND A SPR2021 ANTIGEN

IPC classification:
A61K 39/09, A61K 39/095, A61K 39/385, A61K 47/48, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12769787

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12735420

IMMUNOGENIC COMBINATION COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/12, A61K 39/295, C07K 14/015, C07K 14/045
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12738679

LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

IPC classification:
A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12781365

FERMENTATION MEDIA FREE OF ANIMAL-DERIVED COMPONENTS FOR PRODUCTION OF DIPHTHERIA TOXOIDS SUITABLE FOR HUMAN VACCINE USE

IPC classification:
A61K 39/05
Applicant:
Novartis AG
Agent:
Multiple attorneys, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12738311

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 9/127, A61K 39/00
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12743273

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 9/107, A61K 39/00, A61K 47/06, A61K 47/24
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP12818607

ASSAY FOR INFLUENZA VIRUS HEMAGGLUTININS

IPC classification:
G01N 33/569
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12812257

STABLE COMPOSITIONS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11811574

ADJUVANTED COMBINATIONS OF MENINGOCOCCAL FACTOR H BINDING PROTEINS

IPC classification:
A61K 39/095, A61P 31/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13703562

PROMOTERS FOR INCREASED PROTEIN EXPRESSION IN MENINGOCOCCUS

IPC classification:
C12N 15/63, C12N 15/74
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13710321

ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS

IPC classification:
A61K 31/4375, A61K 31/66, A61K 33/08, A61K 33/42, A61K 39/09, A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13708414

COMBINATION VACCINES WITH TLR4 AGONISTS

IPC classification:
A61K 39/05, A61K 39/08, A61K 39/116
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13709394

ADJUVANTED FORMULATIONS OF RABIES VIRUS IMMUNOGENS

IPC classification:
A61K 39/395, C07D 471/04, C07D 487/04
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13708142

IMMUNOLOGICALLY USEFUL ARGININE SALTS

IPC classification:
A61K 31/4375, A61P 37/04, C07D 471/04
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP13724265

MENINGOCOCCUS SEROGROUP X CONJUGATE

IPC classification:
A61K 39/095, A61K 47/48, A61P 31/04, G01N 30/06, G01N 30/96
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP13726225

IMPROVED SAFETY TESTING

IPC classification:
A61K 39/12, C12Q 1/68
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION WITHDRAWN
EP13747515

VACCINES FOR SEROGROUP X MENINGOCOCCUS

IPC classification:
A61K 39/095
Applicant:
Novartis AG
Applicant:
Institut Pasteur
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13729364

STABILIZED GP120

IPC classification:
A61K 39/21, C07K 14/005
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13736518

COMPLEXES OF CYTOMEGALOVIRUS PROTEINS

IPC classification:
A61K 39/245, C07K 14/045, C12N 7/02
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13732536

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 39/21
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP13758802

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 38/16, A61K 39/085, C07K 1/113, C07K 14/31, C07K 14/315
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13758801

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 38/16, A61K 39/085, C07K 1/113, C07K 14/315
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13753327

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13771400

STABILISED PROTEINS FOR IMMUNISING AGAINST STAPHYLOCOCCUS AUREUS

IPC classification:
A61K 39/085, C07K 14/31
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP13758877

COMBINATION VACCINES WITH SEROGROUP B MENINGOCOCCUS AND D/T/P

IPC classification:
A61K 39/095
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP11804867

FLOW CYTOMETRY ANALYSIS OF MATERIALS ADSORBED TO METAL SALTS

IPC classification:
G01N 33/537, G01N 33/569, G01N 33/68, G01N 33/84
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Antoine Courgeon, GlaxoSmithKline
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Status:
The patent has been granted
EP14177182

RSVF trimerization domains

IPC classification:
A61K 39/155, C07K 14/005, C07K 19/00
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14191385

Mammalian cells expressing cytomegalovirus antigens

IPC classification:
A61K 39/245, C07K 14/005, C12N 5/071
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12197549

Compositions comprising pneumococcal antigens

IPC classification:
A61K 39/09, C07K 14/315, C07K 19/00, C12N 1/21
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, GlaxoSmithKline
Agent:
Rachel Margaret Bullett, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14196854

Cytomegalovirus antigens

IPC classification:
A61K 39/12, A61K 39/245, C07K 14/005
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14199441

Purification of streptococcal capsular polysaccharide

IPC classification:
A61K 39/09, C08B 37/00
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION REFUSED
EP15152221

Cytomegalovirus antigens and uses thereof

IPC classification:
A61K 39/245, C07K 14/005, C07K 16/08
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION PUBLISHED
EP15152415

CMV ANTIGENS AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/245, C07K 14/005, C07K 16/08
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
APPLICATION PUBLISHED
EP12704573

ADJUVANT NANOEMULSIONS WITH CRYSTALLISATION INHIBITORS

IPC classification:
A61K 9/107, A61K 31/4375, A61K 47/26, A61K 47/32, A61K 47/44
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Carpmaels & Ransford LLP
Status:
PATENT GRANTED
EP15157068

FLAVIVIRUS REPLICONS

IPC classification:
C12N 15/86
Applicant:
Novartis AG
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Agent:
Ralf Badur, Novartis Pharma AG
Status:
APPLICATION PUBLISHED

Please Sign in to use this feature